Crizotinib targets in glioblastoma stem cells

Glioblastoma stem cells (GSCs) are believed to be involved in the mechanisms of tumor resistance, therapeutic failures, and recurrences after conventional glioblastoma therapy. Therefore, elimination of GSCs might be a prerequisite for the development of successful therapeutic strategies. ALK, ROS1,...

Descripción completa

Detalles Bibliográficos
Autores principales: Junca, Audelaure, Villalva, Claire, Tachon, Gaëlle, Rivet, Pierre, Cortes, Ulrich, Guilloteau, Karline, Balbous, Anaïs, Godet, Julie, Wager, Michel, Karayan‐Tapon, Lucie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Cancer Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673924/
https://www.ncbi.nlm.nih.gov/pubmed/28960893
http://dx.doi.org/10.1002/cam4.1167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673924/
https://www.ncbi.nlm.nih.gov/pubmed/28960893
http://dx.doi.org/10.1002/cam4.1167

Ejemplares similares